Immunic, Inc.IMUXNASDAQ
LOADING
|||
Revenue CAGR (5Y)
—
Margin Trend
stable
Free Cash Flow
($0.1B)
Profitability
Unprofitable
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -49 | -92↓87.2% | -119↓30.4% | -99↑17.0% | -98↑1.2% |
| Net Income | -44 | -93↓111.2% | -120↓29.5% | -94↑22.3% | -101↓7.4% |
| EBITDA | -49 | -92↓87.2% | -86↑5.6% | -99↓14.7% | -98↑1.2% |
| EPS Diluted | -2.81 | -3.92↓39.5% | -3.78↑3.6% | -2.11↑44.2% | -1.00↑52.6% |
1 / 2
Values in millions except EPS · Ratios shown as percentages